Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind placebo-controlled phase II study of 101BHG-D01 inhalation aerosol in Chinese patients with COPD
CTR20251985Phase 2Active
- Sponsor
- Beijing Shuobai Pharmaceutical Technology
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 101BHG-D01 in chronic obstructive pulmonary disease (COPD), sponsored by Beijing Shuobai Pharmaceutical Technology. Started Jul 2025; status: active.
02
Drugs
101BHG-D01
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20251985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251985.